YX9-15618-62982
3 vaccinations
4 coded responses
21 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 995 / AK
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-20
Registered in v-safe
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-21
- 2020-12-22
- 2020-12-24
-
2020-12-26
Health check-in — day 7, dose 1Feeling: Good · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-15
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-08-24
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Survey response — day 35, dose 3MedDRA: Office visit, Pituitary tumour, Pituitary-dependent Cushing's syndrome — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Symptoms: Not COVID related, but diagnosed with Cushings Disease and a Pituitary tumor · Healthcare visit (other): NeurosurgeryMedDRA releases: 2024-11 · check-in free text available
-
2021-09-28
Report sent to call center — day 35, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
-
2021-09-30
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2021-10-05
-
2021-11-23
Survey response — 3 months, dose 3MedDRA: Pituitary-dependent Cushing's syndrome — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cushing's diseaseMedDRA releases: 2024-11 · check-in free text available
-
2021-11-23
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-01
-
2022-02-22
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: COVID positive againMedDRA releases: 2024-11 · check-in free text available
-
2022-08-24
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-08-24
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-08-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-08-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-08-24 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-28 | Successful 2021-09-30 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2021-11-23 | Successful 2022-08-25 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-08-24 | Successful 2022-08-25 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 9 — day 35, dose 3
Symptoms: Not COVID related, but diagnosed with Cushings Disease and a Pituitary tumor
Healthcare visit (other): Neurosurgery
Release 10 — 3 months, dose 3
Symptoms: Cushing's disease
Release 11 — 6 months, dose 3
Symptoms: COVID positive again
Release 12 — 12 months, dose 3
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Pituitary tumour | · | · | ✓ |
| SD | Pituitary-dependent Cushing's syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release